🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
IBI110 is an investigational drug under evaluation for treatment of small c...
Status
Completed
Location
Shanghai Pulmonary Hospital
Start Date
2021-09-07
Trial ID
NCT05026593
Treatments Being Tested
This is a platform study evaluating the safety and efficacy of multiple nov...
Status
Withdrawn
Location
University of California San Francisco Medical Center
Start Date
2022-11-01
Trial ID
NCT05572463
Treatments Being Tested
The purpose of this study is to determine whether treatment with IBI110 sin...
Status
Unknown
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2021-09-27
Trial ID
NCT05039658
Treatments Being Tested
This is an open-label, dose escalation, Phase I study to evaluate the safet...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2019-12-04
Trial ID
NCT04085185
Treatments Being Tested
The main purpose of this study is to evaluate the neoadjuvant therapy effic...
Status
Terminated
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-12-02
Trial ID
NCT05088967
Treatments Being Tested
This is a single-center, prospective, single-arm Phase II clinical study to...
Status
Unknown
Location
Feng Wang
Start Date
2023-10
Trial ID
NCT06078657
Treatments Being Tested
This study aims to investigate the efficacy and safety of combining sintili...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-06-26
Trial ID
NCT06494943
Treatments Being Tested